Buy Granules India, target price Rs 360: Yes Securities
Granules India Ltd., incorporated in the year 1991, is a Mid Cap company (having a market cap of Rs 8328.03 Crore) operating in Pharmaceuticals sector.
Granules India Ltd. key Products/Revenue Segments include Pharmaceuticals and Other Operating Revenue for the year ending 31-Mar-2021.
Financials
For the quarter ended 30-09-2021, the company reported a Consolidated Total Income of Rs 892.68 Crore, up 4.11 % from last quarter Total Income of Rs 857.47 Crore and up 3.64 % from last year same quarter Total Income of Rs 861.34 Crore. Company has reported net profit after tax of Rs 80.68 Crore in latest quarter.
Investment Rationale
The stock has resumed the uptrend after breaking out of a narrow consolidation zone on healthy volumes, confirming the bullishness. Further, it is also on the verge of a breakout from a Triangle pattern confirming the bullishness. RSI has also turned upwards from the lower end of the bull zone.
Promoter/FII Holdings
Promoters held 41.98 per cent stake in the company as of 31-Dec-2021, while FIIs owned 21.38 per cent, DIIs 4.34 per cent.
(Disclaimer: Recommendations given in this section or any reports attached herein are authored by an external party. Views expressed are that of the respective authors/entities. These do not represent the views of Economic Times (ET). ET does not guarantee, vouch for, endorse any of its contents and hereby disclaims all warranties, express or implied, relating to the same. Please consult your financial adviser and seek independent advice.
Stay connected with us on social media platform for instant update click here to join our Twitter, & Facebook
We are now on Telegram. Click here to join our channel (@TechiUpdate) and stay updated with the latest Technology headlines.
For all the latest Education News Click Here
For the latest news and updates, follow us on Google News.